Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126199 | SCV000169694 | benign | not specified | 2011-07-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000126199 | SCV000308568 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000406103 | SCV000439330 | likely benign | Mitochondrial DNA depletion syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000348879 | SCV000484006 | likely benign | Cytochrome-c oxidase deficiency disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000402916 | SCV000484007 | likely benign | Fatal Infantile Cardioencephalomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000676462 | SCV001146576 | benign | not provided | 2019-04-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000676462 | SCV001721775 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676462 | SCV000802244 | benign | not provided | 2016-02-29 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001276277 | SCV001462371 | benign | Mitochondrial neurogastrointestinal encephalomyopathy | 2020-09-16 | no assertion criteria provided | clinical testing |